Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.

Advanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body composition...

Full description

Bibliographic Details
Main Authors: Eun Young Kim, Nambeom Kim, Young Saing Kim, Ja-Young Seo, Inkeun Park, Hee Kyung Ahn, Yu Mi Jeong, Jeong Ho Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5051688?pdf=render
id doaj-460b07ca76544d06b09fa5b7d82c6049
record_format Article
spelling doaj-460b07ca76544d06b09fa5b7d82c60492020-11-24T22:04:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016405610.1371/journal.pone.0164056Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.Eun Young KimNambeom KimYoung Saing KimJa-Young SeoInkeun ParkHee Kyung AhnYu Mi JeongJeong Ho KimAdvanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body composition. The purpose was to evaluate prognostic value of modified ALI (mALI) using CT-determined L3 muscle index (L3MI, muscle area at L3/height2) beyond original ALI.L3MIs were calculated using the CT images of 186 consecutive patients with SCLC taken at diagnosis, and mALI was defined as L3MI x serum albumin/NLR. Using chi-squared test determined maximum cut-offs for low ALI and low mALI, the prognostic values of low ALI and low mALI were tested using Kaplan-Meier method and Cox proportional hazards analysis. Finally, deviance statistics was used to test whether the goodness of fit of the prognostic model is improved by adding mALI as an extra variable.Patients with low ALI (cut-off, 31.1, n = 94) had shorter OS than patients with high ALI (median, 6.8 months vs. 15.8 months; p < 0.001), and patients with low mALI (cut-off 67.7, n = 94) had shorter OS than patients with high mALI (median, 6.8 months vs. 16.5 months; p < 0.001). There was no significant difference in estimates of median survival time between low ALI and low mALI (z = 0.000, p = 1.000) and between high ALI and high mALI (z = 0.330, p = 0.740). Multivariable analysis showed that low ALI was an independent prognostic factor for shorter OS (HR, 1.67, p = 0.004), along with advanced age (HR, 1.49, p = 0.045), extensive disease (HR, 2.27, p < 0.001), supportive care only (HR, 7.86, p < 0.001), and elevated LDH (HR, 1.45, p = 0.037). Furthermore, goodness of fit of this prognostic model was not significantly increased by adding mALI as an extra variable (LR difference = 2.220, p = 0.136).The present study confirms mALI using CT-determined L3MI has no additional prognostic value beyond original ALI using BMI. ALI is a simple and useful prognostic indicator in SCLC.http://europepmc.org/articles/PMC5051688?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Eun Young Kim
Nambeom Kim
Young Saing Kim
Ja-Young Seo
Inkeun Park
Hee Kyung Ahn
Yu Mi Jeong
Jeong Ho Kim
spellingShingle Eun Young Kim
Nambeom Kim
Young Saing Kim
Ja-Young Seo
Inkeun Park
Hee Kyung Ahn
Yu Mi Jeong
Jeong Ho Kim
Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
PLoS ONE
author_facet Eun Young Kim
Nambeom Kim
Young Saing Kim
Ja-Young Seo
Inkeun Park
Hee Kyung Ahn
Yu Mi Jeong
Jeong Ho Kim
author_sort Eun Young Kim
title Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
title_short Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
title_full Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
title_fullStr Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
title_full_unstemmed Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
title_sort prognostic significance of modified advanced lung cancer inflammation index (ali) in patients with small cell lung cancer_ comparison with original ali.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Advanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body composition. The purpose was to evaluate prognostic value of modified ALI (mALI) using CT-determined L3 muscle index (L3MI, muscle area at L3/height2) beyond original ALI.L3MIs were calculated using the CT images of 186 consecutive patients with SCLC taken at diagnosis, and mALI was defined as L3MI x serum albumin/NLR. Using chi-squared test determined maximum cut-offs for low ALI and low mALI, the prognostic values of low ALI and low mALI were tested using Kaplan-Meier method and Cox proportional hazards analysis. Finally, deviance statistics was used to test whether the goodness of fit of the prognostic model is improved by adding mALI as an extra variable.Patients with low ALI (cut-off, 31.1, n = 94) had shorter OS than patients with high ALI (median, 6.8 months vs. 15.8 months; p < 0.001), and patients with low mALI (cut-off 67.7, n = 94) had shorter OS than patients with high mALI (median, 6.8 months vs. 16.5 months; p < 0.001). There was no significant difference in estimates of median survival time between low ALI and low mALI (z = 0.000, p = 1.000) and between high ALI and high mALI (z = 0.330, p = 0.740). Multivariable analysis showed that low ALI was an independent prognostic factor for shorter OS (HR, 1.67, p = 0.004), along with advanced age (HR, 1.49, p = 0.045), extensive disease (HR, 2.27, p < 0.001), supportive care only (HR, 7.86, p < 0.001), and elevated LDH (HR, 1.45, p = 0.037). Furthermore, goodness of fit of this prognostic model was not significantly increased by adding mALI as an extra variable (LR difference = 2.220, p = 0.136).The present study confirms mALI using CT-determined L3MI has no additional prognostic value beyond original ALI using BMI. ALI is a simple and useful prognostic indicator in SCLC.
url http://europepmc.org/articles/PMC5051688?pdf=render
work_keys_str_mv AT eunyoungkim prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT nambeomkim prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT youngsaingkim prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT jayoungseo prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT inkeunpark prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT heekyungahn prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT yumijeong prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT jeonghokim prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
_version_ 1725831111005700096